自体免疫疾病课件.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《自体免疫疾病课件.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 免疫 疾病 课件
- 资源描述:
-
1、自体免疫疾病器官特异性非器官特异性自体免疫疾病自体免疫疾病肌肉肾脏皮肤关节Pathological Factors in Rheumatic Disorders Rheumatic diseases are multisystem disorders caused by tissue damage resulting from autoantibodies,cytotoxic T lymphocytes,complement-fixing immune complex deposition,and inflammatory mediatorsInflammatory ParametersnES
2、RESRnAcute phase reactantsAcute phase reactantsnImmunoglobulinsImmunoglobulinsnComplement componentsComplement componentsnInflammatory mediators:cytokines,Inflammatory mediators:cytokines,prostanoidsprostanoids ESR are determined by the three forces Surface free energy(Van de Waals force):cohesive f
3、orce Electrical charge associated with RBC:repulsive force Dielectric constant of the medium:dissipates the forceCalculation Equation for ESR Vs=2/9x(Ps-PL)R2/n x gVs=2/9x(Ps-PL)R2/n x gVs=the limiting velocity of the sphereVs=the limiting velocity of the sphereR=the radius of the sphereR=the radius
4、 of the spherePs and PL=the densities of the sphere and Ps and PL=the densities of the sphere and of the liquidof the liquidg=the acceleration due to gravityg=the acceleration due to gravityn=the viscosity of the liquidn=the viscosity of the liquidSerum Proteins and Drugs That Affect the ESR RateESR
5、 increaseESR decrease Fibrinogen ACTH Immunoglobulins Cortisone Dextran Ethambutol Methyldopa Quinine Procainamide Salicylate Oral contraceptives Penicillamine Methylsergide Theophylline Trifluperidol Vitamine AAcute Phase ReactantsThe Acute Phase Response Follows Cell Injury and The Acute Phase Res
6、ponse Follows Cell Injury and Tissue Damage Caused by:Tissue Damage Caused by:Acute infections:i.e.,bacterial or parasiticAcute infections:i.e.,bacterial or parasiticTrauma:i.e.,blunt,surgery,and burnsTrauma:i.e.,blunt,surgery,and burnsIschemic necrosis:i.e.,acute myocardial Ischemic necrosis:i.e.,a
7、cute myocardial infarctioninfarctionMalignant disease:I.e.,tumor growth and Malignant disease:I.e.,tumor growth and metastasismetastasisConnective tissue disease:i.e.,rheumatoid Connective tissue disease:i.e.,rheumatoid arthritis,rheumatic fever and othersarthritis,rheumatic fever and othersAcute ab
8、dominal inflammation:i.e.cholecystitis Acute abdominal inflammation:i.e.cholecystitis and pancreatitisand pancreatitisVaccination:I.e.,typhoidVaccination:I.e.,typhoidFunctional Properties of Human Acute Phase ProteinsFunctional GroupProteinFunctionHost defense proteinsC-reactive protein(CRP)Compleme
9、nt activation,opsonicationMannan-binding protein(MBP)Complement activation,opsonizationComplement proteins C3,C4,C5 Factor B,C9 Factor H,C4bpIncreased vascular permeability,opsonization,bacterial killingFibrinogenFormation of hemostatic plugs,wound healingProteinase inhibitors 1-Proteinase inhibitor
10、(1-PI)Control of extracellular matrix degradation 1-Antichymotrypsin(1-Achy)Control of extracellular matrix degradation 2-Antiplasmin(2-AP)Control of plasminC1 inhibitor(C1 INH)Control of complement and contace system activationAntioxidantsCeruloplaasminInhibition of oxy radical formationHemopexin(H
11、x)Binding of heme,inhibition of lipid peroxidationHaptoglobulin(HP)Binding of hemoglobulin,inhibition of lipid peroxidationFunction unknownSerum amyloid A(SAA)1-Acid glycoproteinC-Reactive Protein(CRP)Normal plasma protein,concentration from Normal plasma protein,concentration from 0.068-8.8 mg/ml0.
12、068-8.8 mg/mlAcute phase reactant,concentration up to Acute phase reactant,concentration up to 500mg/ml500mg/mlSynthesized by hepatocytesSynthesized by hepatocytesMolecular weight 105,500 daltonsMolecular weight 105,500 daltonsFive identical non-glycosylated,non-Five identical non-glycosylated,non-c
13、ovalently associated subunitscovalently associated subunitsAmino acid sequence homologous with serum Amino acid sequence homologous with serum amyloid A component(SAA)amyloid A component(SAA)Rheumatic Disease in Which Elevated C-Reactive Protein Levels may OccurGoutRheumatoid arthritisJuvenile rheum
14、atoid arthritisPsoriatic arthritisAnkylosing spondylitisReiters syndromePolymyalgia rheumatica-giant cell arteritisSystemic vasculitisWegeners granulomatosisBehcets syndromeSystemic lupus erythematosusc ACRc ACR类风湿性关节炎类风湿性关节炎(RA)(RA)类风湿性关节炎类风湿性关节炎(RA)(RA)类风湿性关节炎是一种重要的自体免疫疾病,可导致关节破坏变形,骨骼变化以及全身性的病变。类风
15、湿性关节炎的骨骼变化包括发炎关节旁的骨缺乏,软骨侵蚀。类风湿性关节炎是一种全身性的变化,患者不但关节疼痛,可能关节会逐渐变形。过去十年来,类风湿关节炎在冶疗上的改变有着明显的进步。我们不再视其为一仅局限于关节的慢性病变;反之,却视为一甚富侵略性的全身性疾患。Rheumatoid Arthritis(RA)Rheumatoid Arthritis(RA)A chronic,systemic,autoimmune,A chronic,systemic,autoimmune,inflammatory disease of unknown inflammatory disease of unknown
16、 etiologyetiologyCharacterized by Characterized by persistent intense immunological persistent intense immunological activityactivityinflammatory and erosive inflammatory and erosive synovitis,usually involving synovitis,usually involving peripheral joint in a symmetric peripheral joint in a symmetr
17、ic fashionfashionlocal destruction of bone and local destruction of bone and cartilagecartilagea variety of systemic a variety of systemic manifestation.manifestation.The most common inflammatory joint The most common inflammatory joint diseasediseaseNormal SynoviumNormal SynoviumRheumatoid Synovium
18、Rheumatoid Synoviumc ACRc ACRc Arthritis&Rheumatism Foundationc Arthritis&Rheumatism FoundationPage No.20/52Clinical features of Rheumatoid Clinical features of Rheumatoid Arthritis in the handArthritis in the handEarlyEarly Wasting small muscles Extensor tendon sheath swelling Fusiform swelling of
19、PIP joints MCP joint synovitis with swellingLateLate Deformity Ulnar deviation Swan-neck deformity Subluxation of MCPJ2.Loss of function类风湿性关节炎类风湿性关节炎(RA)(RA)Rheumatoid arthritisRheumatoid arthritis类风湿性关节炎类风湿性关节炎(RA)(RA)类风湿性关节炎类风湿性关节炎(RA)(RA)类风湿关节炎的早期关节破坏类风湿关节炎的早期关节破坏类风湿性关节炎的临床病程类风湿性关节炎的临床病程 变异性极大 只
20、有小于1/5 的病人在发病10-12年内没有出现关节破坏或变形 在发病头六年内关节破坏进展最快(1st2nd3rd.)在发病头两年内对于关节功能的影响最显着Markers of severe disease activity in RAMarkers of severe disease activity in RA1.General polyarthritis involving both small and 1.General polyarthritis involving both small and large large jointsjoints2.Extra-articular di
21、sease,especially nodules and 2.Extra-articular disease,especially nodules and vasculitisvasculitis3.Persistently elevated ESR or CRP with active 3.Persistently elevated ESR or CRP with active synovitissynovitis4.RF-positive with high titier4.RF-positive with high titier5.Radiologically erosions with
展开阅读全文